Back
Monte Rosa Therapeutics Vs. Kyndryl Holdings Industry Stock Comparison
Buy
53
GLUE
Monte Rosa Therapeutics
Last Price:
8.49
Seasonality Move:
-8.98%
Sell
22
KD
Kyndryl Holdings
Last Price:
33.07
Seasonality Move:
21.65%
Buy
53
Monte Rosa Therapeutics (GLUE)
is a Buy
Is Monte Rosa Therapeutics a Buy, Sell or Hold?
- The current Monte Rosa Therapeutics [GLUE] share price is $8.35. The Score for GLUE is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- GLUE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
22
Kyndryl Holdings (KD)
is a Sell
Is Kyndryl Holdings a Buy, Sell or Hold?
- The current Kyndryl Holdings [KD] share price is $32.49. The Score for KD is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- KD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GLUE Stock Price Chart
What is Monte Rosa Therapeutics's stock price today?
-
The Monte Rosa Therapeutics share price today is $8.35
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GLUE is experiencing selling pressure, which indicates risk of future bearish movement.
KD Stock Price Chart
What is Kyndryl Holdings's stock price today?
-
The Kyndryl Holdings share price today is $32.49
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KD is experiencing buying pressure, which is a positive indicator for future bullish movement.
GLUE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.48 | Buy |
| Relative Strength Index (14 RSI): | 54.85 | Buy |
| Chaikin Money Flow: | -376551 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.29 - 9.65) | Buy |
| Bollinger Bands (100): | (4.1 - 7.48) | Buy |
KD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.52 | Buy |
| Relative Strength Index (14 RSI): | 83.94 | Buy |
| Chaikin Money Flow: | 4050180 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.38 - 28.4) | Buy |
| Bollinger Bands (100): | (22.65 - 26.71) | Buy |
GLUE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.32 | Buy |
| 20-day SMA: | 8.67 | Sell |
| 50-day SMA: | 6.71 | Buy |
| 200-day SMA: | 5.63 | Buy |
| 8-day EMA: | 8.37 | Sell |
| 20-day EMA: | 8.13 | Buy |
| 50-day EMA: | 7.13 | Buy |
| 200-day EMA: | 5.88 | Buy |
KD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.77 | Buy |
| 20-day SMA: | 26.27 | Buy |
| 50-day SMA: | 24.78 | Buy |
| 200-day SMA: | 23.96 | Buy |
| 8-day EMA: | 28.86 | Buy |
| 20-day EMA: | 27.1 | Buy |
| 50-day EMA: | 25.54 | Buy |
| 200-day EMA: | 23.47 | Buy |
Monte Rosa Therapeutics Earnings Growth & GLUE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.44 per share, and a decrease next year of $0.60 per share.
Kyndryl Holdings Earnings Growth & KD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.37 per share, and an increase next year of $1.26 per share.
Monte Rosa Therapeutics Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kyndryl Holdings Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||